Pigment Cell & Melanoma Research

Cover image for Vol. 28 Issue 4

Early View (Online Version of Record published before inclusion in an issue)

Edited by: Marcus Bosenberg, Andrew E. Aplin and Heinz Arnheiter - Reviews Editor: Robert Kelsh

Impact Factor: 4.619

ISI Journal Citation Reports © Ranking: 2014: 3/62 (Dermatology); 38/211 (Oncology); 56/184 (Cell Biology)

Online ISSN: 1755-148X


  1. 1 - 4
  1. Letters to the Editor

    1. Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion

      Alexander M. Menzies, Iwei Yeh, Thomas Botton, Boris C. Bastian, Richard A. Scolyer and Georgina V. Long

      Article first published online: 3 JUL 2015 | DOI: 10.1111/pcmr.12388

      • image
      • image
    2. You have full text access to this OnlineOpen article
      Severe gastrointestinal toxicity with administration of trametinib in combination with dabrafenib and ipilimumab

      David R. Minor, Igor Puzanov, Margaret K. Callahan, Bruce A. Hug and Axel Hoos

      Article first published online: 23 JUN 2015 | DOI: 10.1111/pcmr.12383

    3. Expression of oncogenic BRAFV600E in melanocytes induces Schwannian differentiation in vivo

      Chi Luo, Jodie R. Pietruska, Jinghao Sheng, Roderick T. Bronson, Miaofen G. Hu, Rutao Cui and Philip W. Hinds

      Article first published online: 20 JUN 2015 | DOI: 10.1111/pcmr.12384

      • image
      • image
  2. Microenvironment & Immunology (MEI)

    1. Reviews

      You have free access to this content


  1. 1 - 4